Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?
about
Epstein-Barr Virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy.Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation.Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation.Posttransplantation lymphoproliferative disorder after pediatric solid organ transplantation: experiences of 20 years in a single center.Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options.Posttransplant lymphoproliferative disease following liver transplantation.Managing post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens.Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.Post-transplant lymphoproliferative disorder in paediatric patients: the Irish perspective-a single centre experience.Post-transplant lymphoproliferative disorder in the pelvis successfully treated with consolidative radiotherapy.Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD.Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.Post-transplant lymphoproliferative disorders with naso- and oropharyngeal manifestation.Imaging findings in children with proliferative disorders following multivisceral transplantation.Posttransplant lymphoproliferative disorder presenting as a small bowel obstruction in a patient with pancreas transplantation alone.Rituximab, Dexamethasone, Cytarabine, and Cisplatin as Effective Platinum-Based Salvage Chemotherapy for Periportal Posttransplant Lymphoproliferative Disorder After an Orthotopic Liver Transplant.Asymptomatic post-transplant lymphoproliferative disorder diagnosed at one year protocol renal allograft biopsy.A feverish liver transplanted child.Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation.Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study.Impact of the posttransplant lymphoproliferative disorder subtype on survival.The pathological implications of heart transplantation: experience with 50 cases in a single center.Posttransplant Lymphoproliferative Disorder after Cardiac Transplantation in Children: Life Threatening Complications Associated with Chemotherapy Combined with Rituximab
P2860
Q34180551-F2C2F8A4-6C26-45C2-AFD5-310EC4F92277Q34620280-B6BAC333-F8E0-4F87-A606-E57F6BE12BF4Q37012569-63694A02-0E27-4BD2-95BE-798E92C2232AQ37145738-9BF133C2-2D15-457B-8497-DAE22E2161BBQ37740522-ACEBF2D5-A078-45EE-9A4F-73CF316FA10FQ37824825-3F654620-AC87-4354-9228-4FC0143C483CQ37862042-3AB11C82-58A1-4FDB-8B21-2F24BC4B2709Q38032320-6B092087-D062-4B90-A8B5-20CE3CBE78B1Q38108302-1D91E3C8-14D3-4F1D-A9AB-64E4B5E85D06Q38223160-307A390A-AACB-499E-BDAC-448BFFF078C9Q38754851-B364049F-03C3-439A-AAAA-03C8DCE26DD8Q38873735-BA0FDB94-3D82-4D38-B10D-470A037BC240Q40056807-F3914AED-F9B2-4E52-9F1B-6423CAD8F892Q40298660-F2675476-D024-4A19-83E5-BE048838E991Q40765516-F900D8BB-A176-44F9-BF93-45CC3CD6D708Q41398141-17D574D0-99B7-4F18-B20C-A335CE605771Q41978243-04AEB621-5F9F-4D23-8DE2-3AFBE69D2DC3Q42193961-D04020C5-7386-4ECD-9586-F73C6496ED78Q42217743-A77F1053-31FF-43D6-89AB-C4040823EA37Q42266825-C3E30A69-B5AF-49D8-84EF-B3755B0F8255Q42282037-6BA087E4-DD03-42E1-9311-A00CC760BAF0Q47552449-9847766B-7412-4752-B9CC-0A8D8448C46DQ51734713-72DEA4B5-1E3B-4231-A250-10C49FB3B8F1Q53467883-8B04F91B-5581-4493-8580-0DF120E6ACEFQ58998353-0475B27E-8E5F-492A-99B4-BA3178DE5D26
P2860
Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Post-transplant lymphoprolifer ...... approach to a protean disease?
@en
Post-transplant lymphoprolifer ...... approach to a protean disease?
@nl
type
label
Post-transplant lymphoprolifer ...... approach to a protean disease?
@en
Post-transplant lymphoprolifer ...... approach to a protean disease?
@nl
prefLabel
Post-transplant lymphoprolifer ...... approach to a protean disease?
@en
Post-transplant lymphoprolifer ...... approach to a protean disease?
@nl
P2093
P2860
P356
P1476
Post-transplant lymphoprolifer ...... approach to a protean disease?
@en
P2093
Bartosz Foroncewicz
Bogna Ziarkiewicz-Wróblewska
Marek Krawczyk
P2860
P304
P356
10.1093/NDT/GFQ231
P407
P577
2010-07-01T00:00:00Z